13-valent pneumococcal vaccine: 50 years of age and older.

In adults, the 13-valent pneumococcal conjugate vaccine seems to be more immunogenic than the 23-valent polysaccharide pneumococcal vaccine for most of the 12 shared serotypes. However, in mid-2012, routine vaccination of adults has no proven efficacy.